Navigation Links
Medical World Recognises New Therapy for Reflux Babies
Date:8/25/2009

NINOVE, Belgium, August 25 /PRNewswire/ -- 20% of parents seek medical help because of the frequent regurgitation (spitting up food) of their baby and the accompanying discomfort (crying). Reputed medical journal "Archives of Disease in Childhood" of the "British Medical Journal" group recently published the results of the clinical research project that began at the end of 2006 in the Children's gastroenterology department of the Brussels University Hospital.

The AR bed, a development of the MULTICARE Company and the Brussels University Hospital, was investigated in a group of babies that regurgitated and cried a lot, for who medication or adapted food hadn't helped. It was determined that the "AR bed" resulted in less regurgitation and crying in 3/4 of the babies. In addition, it was objectively established that the reflux index (% of time when there is acid in the oesophagus, measured with pH metry) almost halved within a week.

Taking account of the period of despair to desperation among parents and their baby, whether or not combined with various examinations (oesophagoscopy , pH metry, etc.), in their search for a suitable adaptation of food and medication, the AR bed[1] can offer comfort much sooner: in general, improvement is noticed within a day.

The AR bed is now suggested by paediatricians as a first step in the treatment of regurgitation and/or gastro-oesophageal reflux. Apart from reassuring parents, a nutritional approach (adapted volume, thickened Anti-Regurgitation food); this posture therapy contributes to the decrease of complaints. This is a major step forward in ending the spiral of medication overuse in babies who spit up food and cry a lot.

Professor Y. Vandenplas: "Medication is mainly of use in reflux disease, i.e. acid reflux and oesophagitis. Many babies who spit up food do not have reflux disease. In other words, medication has little use for these babies. All medication has potential side effects, which is why avoiding this medication is preferable. Experience with the MULTICARE AR bed has taught us that a fair number of children no longer needed to take medication."

More information can be found on http://www.multicare.be/eng/arbedeng.html

---------------------------------

[1] The MULTICARE AR bed is already available in Belgium through pharmacies (distributor Aprophar TGZ) and can be rented at a daily price of EUR1.75. Home delivery transport cost is EUR 12.10, disinfection + cleaning is EUR 15.00. Option to buy a sleeping bag: EUR 40.00.

The manufacturer, PEOS bvba, is looking for a UK-based distributor that is able to offer the general public the same service.


'/>"/>
SOURCE PEOS bvba
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 Under ... Chinese pharmaceutical packaging market size increased year by ... From 2017 to 2021, the market size will ... is expected to outnumber RMB140 billion in 2021, ... the rapid development of biological agents and supporting ...
(Date:3/22/2017)... Pennsylvania , 22. März 2017 /PRNewswire/ ... unabhängige und weltweit tätige Anbieter von Produkten ... heute den Erwerb von EPL Archives Inc. ... Stoffe, der Kunden im kompletten Zyklus regulierter ... Verwahrung von Proben, Speicherung von Dokumenten und ...
(Date:3/22/2017)... 22, 2017  Applied BioMath ( www.appliedbiomath.com ), ... research and development, today announced the latest line-up ... 2017 is a day full of presentations, posters, ... (QSP) community. The focus is to learn about ... accelerating drug research and development. The ...
Breaking Medicine Technology:
(Date:3/23/2017)... Los Angeles, CA (PRWEB) , ... March 23, 2017 , ... ... half of all Americans, yet poor sleep is likely not the only cause of ... these undesirable characteristics that make you look older or in poor health are likely ...
(Date:3/23/2017)... ... 23, 2017 , ... Corra Group is now offering exclusively ... Verisys through its FACIS and other services maintains the largest healthcare database ... are delighted to be able to offer these various products to our healthcare ...
(Date:3/23/2017)... McKinney, Texas (PRWEB) , ... March 23, 2017 ... ... Operations Command (USSOCOM) awarded Task Force Dagger Foundation the US Special Operations Command’s ... Thomas. During the presentation, General Thomas thanked Task Force Dagger Foundation for its ...
(Date:3/23/2017)... DC (PRWEB) , ... March 23, 2017 , ... News ... Dental Choice has helped score a major victory in Europe for public health and ... , Based on rigorous scientific research and the overwhelming support of European ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... an innovative patient - centric payment system, to expand its focus on patient ... the patient financial experience. , “At Ogden Clinic, we are working to ...
Breaking Medicine News(10 mins):